Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p

Eukaryotic Cell

Volumn 9, Issue 6, 2010, Pages 960-970

  Basso Jr , Luiz R ^a   Gast, Charles E ^a   Mao, Yuxin ^a   Wong, Brian ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CARRIER PROTEIN; CDR1 PROTEIN, CANDIDA ALBICANS; FLUCONAZOLE; FUNGAL PROTEIN; MEMBRANE PROTEIN;

ARTICLE; CANDIDA ALBICANS; DRUG EFFECT; GENETICS; METABOLISM; SECRETORY VESICLE; DRUG EFFECTS;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; FLUCONAZOLE; FUNGAL PROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; SECRETORY VESICLES;

CANDIDA ALBICANS; FUNGI;

EID: 77953803183     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00355-09     Document Type: Article

References (59)

1. Banerjee, D., N. Martin, S. Nandi, S. Shukla, A. Dominguez, G. Mukhopadhyay, and R. Prasad. 2007. A genome-wide steroid response study of the major human fungal pathogen Candida albicans. Mycopathologia 164:1-17.
2. Cannon, R. D., F. J. Fischer, K. Niimi, M. Niimi, and M. Arisawa. 1998. Drug pumping mechanisms in Candida albicans. Nippon Ishinkin Gakkai Zasshi 39:73-78.
3. Chen, C. G., Y. L. Yang, H. I. Shih, C. L. Su, and H. J. Lo. 2004. CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob. Agents Chemother. 48:4505-4512.
4. Chen, C. G., Y. L. Yang, K. Y. Tseng, H. I. Shih, C. H. Liou, C. C. Lin, and H. J. Lo. 2009. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans. Fungal Genet. Biol. 46:714-720.
5. Cheng, G., K. M. Yeater, and L. L. Hoyer. 2006. Cellular and molecular biology of Candida albicans estrogen response. Eukaryot. Cell 5:180-191.
6. Coste, A., V. Turner, F. Ischer, J. Morschhäuser, A. Forche, A. Selmecki, J. Berman, J. Bille, and D. Sanglard. 2006. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172:2139-2156.
7. Coste, A. T., J. Crittin, C. Bauser, B. Rohde, and D. Sanglard. 2009. Functional analysis of cis- and transacting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system. Eukaryot. Cell 8:1250-1267.
8. Coste, A. T., M. Karababa, F. Ischer, J. Bille, and D. Sanglard. 2004. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3:1639-1652.
9. Coury, L. A., J. C. Mathai, G. V. Prasad, J. L. Brodsky, P. Agre, and M. L. Zeidel. 1998. Reconstitution of water channel function of aquaporins 1 and 2 by expression in yeast secretory vesicles. Am. J. Physiol. 274:F34-F42.
10. de Micheli, M., J. Bille, C. Schueller, and D. Sanglard. 2002. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol. Microbiol. 43:1197-1214.
11. Dogra, S., S. Krishnamurthy, V. Gupta, B. L. Dixit, C. M. Gupta, D. Sanglard, and R. Prasad. 1999. Asymmetric distribution of phosphatidyletha-nolamine in C. albicans: possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast 15:111-121.
12. Dunkel, N., J. Blass, P. D. Rogers, and J. Morschhäuser. 2008. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol. Microbiol. 69:827-840.
13. Gaur, N. A., R. Manoharlal, P. Saini, T. Prasad, G. Mukhopadhyay, M. Hoefer, J. Morschhäuser, and R. Prasad. 2005. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element. Biochem. Biophys. Res. Commun. 332:206-214.
14. Gauthier, C., S. Weber, A. M. Alarco, O. Alqawi, R. Daoud, E. Georges, and M. Raymond. 2003. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. Antimicrob. Agents Chemother. 47:1543-1554.
15. Haque, A., V. Rai, B. S. Bahal, S. Shukla, A. A. Lattif, G. Mukhopadhyay, and R. Prasad. 2007. Allelic variants of ABC drug transporter Cdr1p in clinical isolates of Candida albicans. Biochem. Biophys. Res. Commun. 352: 491-497.
16. Hiller, D., D. Sanglard, and J. Morschhäuser. 2006. Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans. Antimicrob. Agents Chemother. 50:1365-1371.
17. Holmes, A. R., Y. H. Lin, K. Niimi, E. Lamping, M. Keniya, M. Niimi, K. Tanabe, B. C. Monk, and R. D. Cannon. 2008. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob. Agents Chemother. 52: 3851-3862.
18. Holmes, A. R., S. Tsao, S. W. Ong, E. Lamping, K. Niimi, B. C. Monk, M. Niimi, A. Kaneko, B. R. Holland, J. Schmid, and R. D. Cannon. 2006. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol. Microbiol. 62:170-186.
19. Ivnitski-Steele, I., A. R. Holmes, E. Lamping, B. C. Monk, R. D. Cannon, and L. A. Sklar. 2009. Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p. Anal. Biochem. 394: 87-91.
20. Kohli, A., V. Gupta, S. Krishnamurthy, S. E. Hasnain, and R. Prasad. 2001. Specificity of drug transport mediated by CaMDR1: a major facilitator of Candida albicans. J. Biosci. 26:333-339.
21. Krishnamurthy, S., V. Gupta, P. Snehlata, and R. Prasad. 1998. Characterization of human steroid hormone transport mediated by Cdr1p, a multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family. FEMS Microbiol. Lett. 158:69-74.
22. Laizé, V., G. Rousselet, J. M. Verbavatz, V. Berthonaud, R. Gobin, N. Roudier, L. Abrami, P. Ripoche, and F. Tacnet. 1995. Functional expression of the human CHIP28 water channel in a yeast secretory mutant. FEBS Lett. 373:269-274.
23. Lamping, E., B. C. Monk, K. Niimi, A. R. Holmes, S. Tsao, K. Tanabe, M. Niimi, Y. Uehara, and R. D. Cannon. 2007. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot. Cell 6:1150-1165.
24. Larsen, B., S. Anderson, A. Brockman, M. Essmann, and M. Schmidt. 2006. Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. Yeast 23:795-802.
25. Lee, S. A., Z. Khalique, C. A. Gale, and B. Wong. 2005. Intracellular trafficking of fluorescently tagged proteins associated with pathogenesis in Candida albicans. Med. Mycol. 43:423-430.
26. Lee, S. A., Y. Mao, Z. Zhang, and B. Wong. 2001. Overexpression of a dominant-negative allele of YPT1 inhibits growth and aspartyl protease secretion in Candida albicans. Microbiology 147:1961-1970.
27. Liu, T. T., R. E. Lee, K. S. Barker, R. E. Lee, L. Wei, R. Homayouni, and P. D. Rogers. 2005. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49:2226-2236.
28. Manoharlal, R., N. A. Gaur, S. L. Panwar, J. Morschhäuser, and R. Prasad. 2008. Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans. Antimicrob. Agents Chemother. 52:1481-1492.
29. Mao, Y., V. F. Kalb, and B. Wong. 1999. Overexpression of a dominant-negative allele of SEC4 inhibits growth and protein secretion in Candida albicans. J. Bacteriol. 181:7235-7242.
30. Morschhäuser, J. 2002. The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta 1587:240-248.
31. Morschhäuser, J., K. S. Barker, T. T. Liu, J. Blaß-Warmuth, R. Homayouni, and P. D. Rogers. 2007. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog. 3:e164.
32. Nakamoto, R. K., R. Rao, and C. W. Slayman. 1991. Expression of the yeast plasma membrane [H ]ATPase in secretory vesicles. A new strategy for directed mutagenesis. J. Biol. Chem. 266:7940-7949.
33. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottignies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2001. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374.
34. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
35. Niimi, K., K. Maki, F. Ikeda, A. R. Holmes, E. Lamping, M. Niimi, B. C. Monk, and R. D. Cannon. 2006. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility. Antimicrob. Agents Chemother. 50:1148-1155.
36. Niimi, M., K. Niimi, Y. Takano, A. R. Holmes, F. J. Fischer, Y. Uehara, and R. D. Cannon. 2004. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J. Antimicrob. Chemother. 54:999-1006.
37. Pasrija, R., D. Banerjee, and R. Prasad. 2007. Structure and function analysis of CaMdr1p, a major facilitator superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug/H transport. Eukaryot. Cell 6:443-453.
38. Pasrija, R., S. L. Panwar, and R. Prasad. 2008. Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob. Agents Chemother. 52:694-704.
39. Prasad, R., P. de Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
40. Prasad, R., and K. Kapoor. 2005. Multidrug resistance in yeast Candida. Int. Rev. Cytol. 242:215-248.
41. Rao, R., and C. W. Slayman. 1992. Mutagenesis of the yeast plasma membrane H(+)-ATPase. A novel expression system. Biophys. J. 62:228-237.
42. Ruetz, S., and P. Gros. 1994. Functional expression of P-glycoproteins in secretory vesicles. J. Biol. Chem. 269:12277-12284.
43. Ruetz, S., and P. Gros. 1994. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77:1071-1081.
44. Ruetz, S., M. Raymond, and P. Gros. 1993. Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast cells. Proc. Natl. Acad. Sci. U. S. A. 90:11588-11592.
45. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
46. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
47. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
48. Schuetzer-Muehlbauer, M., B. Willinger, R. Egner, G. Ecker, and K. Kuchler. 2003. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int. J. Anti-microb. Agents 22:291-300.
49. Shukla, S., V. Rai, D. Banerjee, and R. Prasad. 2006. Characterization of Cdr1p, a major multidrug efflux protein of Candida albicans: purified protein is amenable to intrinsic fluorescence analysis. Biochemistry 45:2425-2435.
50. Shukla, S., P. Saini, Smriti, S. Jha, S. V. Ambudkar, and R. Prasad. 2003. Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot. Cell 2:1361-1375.
51. Silver, P. M., B. G. Oliver, and T. C. White. 2008. Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance. Med. Mycol. 46:231-239.
52. Smriti, S. Krishnamurthy, B. L. Dixit, C. M. Gupta, S. Milewski, and R. Prasad. 2002. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast 19:303-318.
53. Tsao, S., F. Rahkhoodaee, and M. Raymond. 2009. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob. Agents Chemother. 53:1344-1352.
54. Walther, A., and J. Wendland. 2003. An improved transformation protocol for the human fungal pathogen Candida albicans. Curr. Genet. 42: 339-343.
55. Walworth, N. C., and P. J. Novick. 1987. Purification and characterization of constitutive secretory vesicles from yeast. J. Cell Biol. 105:163-174.
56. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Micro-biol. Rev. 11:382-402.
57. Zeng, Y. B., Y. S. Qian, L. Ma, and H. N. Gu. 2007. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis. Chin. Med. J. (Engl.) 120:807-813.
58. Znaidi, S., X. De Deken, S. Weber, T. Rigby, A. Nantel, and M. Raymond. 2007. The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans. Mol. Microbiol. 66:440-452.
59. Znaidi, S., S. Weber, O. Z. Al-Abdin, P. Bomme, S. Saidane, S. Drouin, S. Lemieux, X. de Deken, F. Robert, and M. Raymond. 2008. Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot. Cell 7:836-847.